Manager, USMA Oncology

Join a Legacy of Innovation 110 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

Summary:

Under the guidance of the Director, the Manager, US Medical Affairs Oncology will contribute to development of the US medical affairs plan for assigned product(s) and ensure optimal execution of planned activities. This includes strategic partnerships with the brand and commercial teams, HEOR (Health Economics Outcomes Research), R&D (Research and Development), FMA (Field Medical Affairs), MI&E (Medical Information and Education) and global functions as necessary to create and implement strategies that support early development, pre-launch, launch and post-approval activities. The role will be participate in advisory activities to obtain feedback; identification and management of key external stakeholders including scientific leaders, payers, and societies; providing US input into global development strategy, design, and deliverables, including scientific communications and publications; scientific engagement planning and coordination; interpretation of clinical data; ensuring consistency of clinical content and scientific statements across materials; training and education of cross-functional internal colleagues; and budget and forecast accuracy.

Responsibilities:

• Cross-functional collaboration to ensure strategic, timely and appropriate scientific communication and engagement activities at major congresses, medical meetings, and other venues; ensure timely release of data supporting core development areas; assure high quality outputs as well as compliance with appropriate internal and external publication practices.

• Responsible for execution (in collaboration with stakeholders as appropriate) of advisory meetings to enhance life cycle management and contribution of the Oncology portfolio to patient care and corporate presence.

• In collaboration with cross-functional stakeholders, develop and implement thought leader engagement plans and ensure the tactical implementation is consistent with company SOPs, rules and regulations.

• Collaborate with internal stakeholders such as development and Global functions in the execution of appropriate Medical Affairs plans to support DSI Corporate, oncology and Brand strategies (including Translational, Commercial, Clinical Development and Sales, as well as, Health Outcomes, Field Medical, Research/Strategy, Regulatory and Legal). Also responsible for therapeutic area training needs of field-based Medical Science Liaisons including the development of training materials and appropriate sessions to maintain high level of clinical expertise in the field of oncology

Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Education Qualifications (from an accredited college or university):

• PharmD Advanced degree in the Health Sciences, such as PharmD, MD or PhD is required; training or experience in a relevant therapeutic area, including breast cancer, NSCLC, and/or other solid tumors required

Experience Qualifications:

• 1 to 3 years of relevant pharmaceutical industry, clinical, and/or academic experience for MD, PharmD, or PhD. Proven track record of working successfully with cross-functional teams to achieve goals. Experience with medical strategies and scientific research/communication plans is preferred

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.